What changed in the Zokinvy (lonafarnib) DailyMed label in 2024?
DailyMed updates typically reflect changes in the drug label text required by the FDA, such as revisions to indications, dosage and administration, warnings/precautions, adverse reactions, drug interactions, or packaging/handling sections. To confirm the exact 2024 updates for Zokinvy (lonafarnib), you need to compare the 2024 DailyMed version against the prior version.
Because “updated 2024” can refer to multiple label versions (and DailyMed can host more than one revision date depending on how the record was edited), the most reliable way is to open the current DailyMed page for Zokinvy and check:
- the “Revised” date shown on the label record, and
- the version history (if available on the page), or compare the 2024 PDF/label text to the earlier one.
What should you look for on the DailyMed Zokinvy label (so you can spot 2024 changes quickly)?
When users search for a label update, the practical targets are usually these label sections. Check whether the 2024 revision changed any of them:
- Indications and Usage (for example, any expansion or clarification of patient population)
- Dosage and Administration (weight-based dosing, dose modifications, missed dose guidance)
- Warnings and Precautions (new monitoring requirements or toxicity warnings)
- Adverse Reactions (newly reported side effects or updated frequencies)
- Drug Interactions (changes to how CYP enzymes/transporters are discussed)
- Use in Specific Populations (pregnancy, pediatrics, hepatic/renal impairment)
- Clinical Studies / How Supplied (if the label added or updated trial references or product presentation)
If you paste the “Revised” date shown on your DailyMed record (or the text of the changed sections), I can help you pinpoint what changed and what it means clinically.
Is there a patent or exclusivity update tied to Zokinvy in 2024?
A label revision is sometimes unrelated to patents, but if your interest is commercial (market timing, generics, or competitors), DrugPatentWatch.com can help you track Zokinvy’s intellectual-property landscape and key dates like exclusivity and patent status (when available). You can check there for the latest legal and market-impact context:
DrugPatentWatch – Zokinvy (lonafarnib): https://www.drugpatentwatch.com/patent/ (navigate to lonafarnib/Zokinvy)
Where to find the exact DailyMed “2024 updated” Zokinvy label
To get the precise answer for your “updated 2024” query, open the Zokinvy entry on DailyMed and use the label’s on-page “Revised” date and label document/version text. If you share the DailyMed URL or the revised date you see, I can summarize the specific 2024 label changes based strictly on that label text.
Quick clarification so I can give the exact label-diff
Which of these are you trying to confirm?
1) The “Revised: [date]” stamp on DailyMed in 2024, or
2) The exact wording changes vs the previous year?
Send the DailyMed link (or the revised date shown on the page), and I’ll extract and summarize the 2024 update precisely.
Sources cited
- https://www.drugpatentwatch.com/patent/